Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-007498
Filing Date
2025-05-13
Accepted
2025-05-13 08:09:19
Documents
72
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mgtx-20250331x10q.htm   iXBRL 10-Q 2001259
2 EX-10.1 mgtx-20250331xex10d1.htm EX-10.1 401303
3 EX-31.1 mgtx-20250331xex31d1.htm EX-31.1 11269
4 EX-31.2 mgtx-20250331xex31d2.htm EX-31.2 13848
5 EX-32.1 mgtx-20250331xex32d1.htm EX-32.1 6660
6 EX-32.2 mgtx-20250331xex32d2.htm EX-32.2 6668
  Complete submission text file 0001558370-25-007498.txt   8782615

Data Files

Seq Description Document Type Size
7 EX-101.SCH mgtx-20250331.xsd EX-101.SCH 62536
8 EX-101.CAL mgtx-20250331_cal.xml EX-101.CAL 54253
9 EX-101.DEF mgtx-20250331_def.xml EX-101.DEF 220009
10 EX-101.LAB mgtx-20250331_lab.xml EX-101.LAB 454352
11 EX-101.PRE mgtx-20250331_pre.xml EX-101.PRE 382515
75 EXTRACTED XBRL INSTANCE DOCUMENT mgtx-20250331x10q_htm.xml XML 1384683
Mailing Address 450 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016
Business Address 450 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016 646-860-7985
MeiraGTx Holdings plc (Filer) CIK: 0001735438 (see all company filings)

EIN.: 981448305 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38520 | Film No.: 25937261
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)